Atossa Genetics (ATOS) Reports Q2 Loss of $0.11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ATOS Hot Sheet
Join SI Premium – FREE
Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.
For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- AppFolio (APPF) Tops Q3 EPS by 3c; Offers Outlook
- Customers Bancorp (CUBI) Tops Q3 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
